Competition for additional information. The genetic medicine field is relatively new and evolving rapidly. Because of our limited technical, financial and human resources, we are focusing our research and development efforts on detalimogene, as well as further development of our genetic medicine platform and other product candidates we may develop. As a result, we may forego or delay pursuit of other genetic medicine technologies or other therapeutic product candidates that provide significant a...
Q2 FY2026 — expected 2026-09-12
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-12-22 | 2025-10-31 | 0001193125-25-328743 | EDGAR | 107K words |
| 2024-12-19 | 2024-10-31 | 0000950170-24-138472 | EDGAR | — |
| 2024-01-29 | 2023-10-31 | 0000950170-24-008125 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2026-01-31 | 0001193125-26-097541 | EDGAR | 24K words |
| 2025-09-11 | 2025-07-31 | 0000950170-25-114224 | EDGAR | — |
| 2025-06-12 | 2025-04-30 | 0000950170-25-085143 | EDGAR | — |
| 2025-03-10 | 2025-01-31 | 0000950170-25-036281 | EDGAR | — |
| 2024-09-10 | 2024-07-31 | 0000950170-24-105180 | EDGAR | — |
| 2024-06-14 | 2024-04-30 | 0000950170-24-073330 | EDGAR | — |
| 2024-03-11 | 2024-01-31 | 0000950170-24-029413 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001193125-26-344559 | EDGAR | — |
| 2026-07-17 | 0001193125-26-307795 | EDGAR | — |
| 2026-07-16 | 0001193125-26-305418 | EDGAR | — |
| 2026-03-09 | 0001193125-26-097546 | EDGAR | 26K words |
| 2026-03-09 | 0001193125-26-097534 | EDGAR | — |
| 2026-01-21 | 0001193125-26-017945 | EDGAR | — |
| 2026-01-21 | 0001193125-26-017226 | EDGAR | — |
| 2025-12-22 | 0001193125-25-328706 | EDGAR | — |
| 2025-11-14 | 0001193125-25-283182 | EDGAR | — |
| 2025-11-12 | 0001193125-25-275722 | EDGAR | — |
64 total filings indexed. 44 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001980845 |
| Ticker | ENGN |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | Z4 |
| Website | https://www.engene.com |
| Listed | 2023-11-01 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ENGN (~200 tokens, structured JSON with cryptographic provenance)